2004
DOI: 10.1007/s11094-005-0001-7
|View full text |Cite
|
Sign up to set email alerts
|

Calculation of the bioaccessibility of drugs using data on the similarity of their molecular structures

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2009
2009
2014
2014

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 23 publications
0
2
0
Order By: Relevance
“…Yes/No, Positive/Negative), three [24] (high with F > 80 %; moderate with F = 21-79 %, and low with F < 20 %), or four groups [25] (1: < 20 %, 2: 20-49 %; 3: 50-79 %; 4: > 80 %).…”
Section: Prognosis Of Bioavailabilitymentioning
confidence: 99%
See 1 more Smart Citation
“…Yes/No, Positive/Negative), three [24] (high with F > 80 %; moderate with F = 21-79 %, and low with F < 20 %), or four groups [25] (1: < 20 %, 2: 20-49 %; 3: 50-79 %; 4: > 80 %).…”
Section: Prognosis Of Bioavailabilitymentioning
confidence: 99%
“…Generally, these rules obtained from database analysis can be used to distinguish well-absorbed molecules from poorly-absorbed molecules. Among numerous attempts to find relevant correlation between physico-chemical properties of API and their bioavailability the "rule of five" is the most popular ADME-concerned filters, and most widely used [24]. The "rule of five" defined several rules for identifying compounds with possible poor absorption and permeability: (1) molecular weight > 500, (2) calculated log P > 5 (CLOGP) or > 4.15 (MLOGP), (3) number of hydrogen bond donors (OH and NH groups) > 5, and (4) number of hydrogen-bond acceptors (N and O atoms) > 10.…”
Section: Prognosis Of Bioavailabilitymentioning
confidence: 99%